Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7947906 | 0.85 | KMT2A (0.48) | GPR84FFAR1FFAR4ALDH1A1KMT2A | |
| SCHEMBL7951205 | 0.85 | ALDH1A1 (0.53) | ALDH1A1KMT2AMAPTTSHR | |
| SCHEMBL11623313 | 0.85 | KMT2A (0.48) | GPR84FFAR1FFAR4ALDH1A1KMT2A | |
| SCHEMBL2302039 | 0.85 | KMT2A (0.48) | GPR84FFAR1FFAR4ALDH1A1KMT2A | |
| SCHEMBL11626606 | 0.85 | KMT2A (0.48) | GPR84FFAR1FFAR4ALDH1A1KMT2A | |
| SCHEMBL7950973 | 0.85 | KMT2A (0.48) | GPR84FFAR1FFAR4ALDH1A1KMT2A | |
| SCHEMBL7563843 | 0.85 | KMT2A (0.48) | GPR84FFAR1FFAR4ALDH1A1KMT2A | |
| SCHEMBL2304429 | 0.82 | KMT2A (0.45) | GPR84FFAR1FFAR4ALDH1A1KMT2A | |
| SCHEMBL16319001 | 0.81 | PPARD (0.47) | GPR84FFAR1FFAR4KDM4ESMN1; SMN2 | |
| SCHEMBL4939652 | 0.80 | ALDH1A1 (0.42) | ALDH1A1KMT2AMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120041229-A1 | METHODS FOR MANUFACTURING TETRANOR-PROSTAGLANDIN D, J, E, A AND F METABOLITES | CAYMAN CHEMICAL COMPANY, INCORPORATED (US) | 2012-02-16 | — | — | US | disclosed |
| EP-0084408-A1 | Bicyclooctane compounds and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041229-A1 | METHODS FOR MANUFACTURING TETRANOR-PROSTAGLANDIN D, J, E, A AND F METABOLITES | PTGES, PTGDR, PTGIR | GPR84 1506/4885FFAR1 135/4885FFAR4 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.